Internal Medicine, Rheumatology · Indianapolis, IN
NPI
1225010887
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5255 E Stop 11 Rd Ste 320
Indianapolis, IN, 46237
Phone (317) 888-1467
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
4,604 services
Medicare patients, 2024
360
Average age 73
Drug cost, 2024
$3.5M
3,555 prescriptions
Company payments, 2025
$3,265
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James W Ehlich Jr. was code J0897 (injection, denosumab, 1 mg), 3,960 times for 54 patients. In total James W Ehlich Jr. billed 4,604 services in 15 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,960 | 54 | $19.71 | $78K |
| 99214 Office E&M - Established | Office | 137 | 116 | $71.03 | $9,731 |
| 99214 Office E&M - Established | Facility | 122 | 94 | $69.49 | $8,478 |
| 99213 Office E&M - Established | Office | 102 | 94 | $50.05 | $5,105 |
| 99213 Office E&M - Established | Facility | 86 | 82 | $47.26 | $4,065 |
| 99204 Office E&M - New | Office | 70 | 70 | $92.34 | $6,464 |
| 96372 Injection Administration | Office | 67 | 55 | $10.52 | $705 |
| 99204 Office E&M - New | Facility | 39 | 39 | $91.31 | $3,561 |
By year: 2022 $298K for 34,636 services; 2023 $208K for 15,201 services; 2024 $117K for 4,604 services.
Medicare prescription drug claims, 2024
In 2024, the drug James W Ehlich Jr. prescribed most often to Medicare patients was Prednisone, with 513 prescriptions and refills. In total James W Ehlich Jr. wrote 3,555 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 513 | 899 | 159 | $3,526 |
| Hydroxychloroquine Sulfate Generic | 482 | 1,136 | 156 | $13K |
| Methotrexate Methotrexate Sodium | 450 | 1,000 | 141 | $9,940 |
| Leflunomide Generic | 255 | 618 | 95 | $20K |
| Alendronate Sodium Generic | 212 | 558 | 80 | $1,372 |
| Allopurinol Generic | 163 | 442 | 49 | $1,093 |
| Humira(Cf) Pen Adalimumab | 99 | 108 | 14 | $890K |
| Sulfasalazine Generic | 85 | 207 | 29 | $2,723 |
| Mycophenolate Mofetil Generic | 78 | 142 | 24 | $8,811 |
| Meloxicam Generic | 77 | 184 | 30 | $387 |
| Celecoxib Generic | 71 | 157 | 26 | $2,376 |
| Folic Acid Generic | 69 | 181 | 24 | $563 |
| Azathioprine Generic | 62 | 117 | 16 | $1,379 |
| Rinvoq Upadacitinib | 61 | 65 | 12 | $410K |
| Colchicine Generic | 59 | 151 | 22 | $6,389 |
Brand drugs: 610 claims; generic drugs: 2,917 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James W Ehlich Jr. $3,265 ($3,265 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $899.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $899 |
| UCB, Inc. UCB.BR | 12 | $618 |
| Amgen Inc. AMGN | 16 | $474 |
| Janssen Biotech, Inc. JNJ | 7 | $397 |
| Radius Health, Inc. | 10 | $250 |
| GlaxoSmithKline, LLC. GSK | 2 | $201 |
| Pfizer Inc. PFE | 5 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $102 |
| Lilly USA, LLC LLY | 1 | $90.9 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $65.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.